K161461 is an FDA 510(k) clearance for the BostonSight PD Prosthetic Device. Classified as Lens, Contact (other Material) - Daily (product code HQD), Class II - Special Controls.
Submitted by Bostonsight (Needham, US). The FDA issued a Cleared decision on July 25, 2016 after a review of 60 days - a notably fast clearance cycle.
This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.5916 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.